Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 30, 2020 - Issue 5
Submit an article Journal homepage
285
Views
5
CrossRef citations to date
0
Altmetric
Review

Anaplastic lymphoma kinase inhibitors: an updated patent review (2014–2018)

Yi-Min LiuTMU Biomedical Commercialization Center, Taipei Medical University, Taipei, Taiwan;Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, JapanView further author information
,
Chun-Nan KuoSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan;Department of Pharmacy, Taipei Medical University, Taipei Municipal Wanfang Hospital, Taipei, TaiwanView further author information
&
Jing-Ping LiouTMU Biomedical Commercialization Center, Taipei Medical University, Taipei, Taiwan;School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, TaiwanCorrespondence[email protected]
View further author information
Pages 351-373 | Received 05 Sep 2019, Accepted 02 Mar 2020, Published online: 12 Mar 2020

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Deyi Ma, Mengrao Guo & Xin Zhai. (2023) An updated patent review of anaplastic lymphoma kinase inhibitors (2018–2022). Expert Opinion on Therapeutic Patents 33:4, pages 323-337.
Read now

Articles from other publishers (4)

Hussein Sabit, Mohamed Abdel-Hakeem, Tahsin Shoala, Shaimaa Abdel-Ghany, Mokhtar Mamdouh Abdel-Latif, Jawaher Almulhim & Mohamed Mansy. (2022) Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs. Pharmaceutics 14:8, pages 1566.
Crossref
Xiaoxia Liang, Pan Wu, Qian Yang, Yunyu Xie, Changliang He, Lizi Yin, Zhongqiong Yin, Guizhou Yue, Yuanfeng Zou, Lixia Li, Xu Song, Cheng Lv, Wei Zhang & Bo Jing. (2021) An update of new small-molecule anticancer drugs approved from 2015 to 2020. European Journal of Medicinal Chemistry 220, pages 113473.
Crossref
Xiaoxia Liang, Qian Yang, Pan Wu, Changliang He, Lizi Yin, Funeng Xu, Zhongqiong Yin, Guizhou Yue, Yuanfeng Zou, Lixia Li, Xu Song, Cheng Lv, Wei Zhang & Bo Jing. (2021) The synthesis review of the approved tyrosine kinase inhibitors for anticancer therapy in 2015–2020. Bioorganic Chemistry 113, pages 105011.
Crossref
Oi Wei Mak, Nabangshu Sharma, Jóhannes Reynisson & Ivanhoe K.H. Leung. (2021) Discovery of novel Hsp90 C-terminal domain inhibitors that disrupt co-chaperone binding. Bioorganic & Medicinal Chemistry Letters 38, pages 127857.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.